Simulations Plus, Inc.

web

Ad Details

  • Ad ID: 64956

  • Added: August 22, 2024

  • Location: United States

  • State: California

  • City: Lancaster

  • Company Name: Simulations Plus, Inc.

  • Keywords: modeling, simulation software & consulting services, admetox screening, data mining, library design, pbpk, pd modeling, ivivcs, drugdrug interactions, virtual population trials, nonlinear metabolism, transport, metabolite tracking, pk, pd modeling & simulation, pbpk modeling, simulation, drug development, regulatory writing, quantitative systems pharmacology, clinical pharmacology, modelbased drug discovery, development, admet property estimation, qsar modeling, analysis, qsp, qst modeling, onsite training, quantitative systems toxicology, endtoend in silico solutions, pharmacometrics, nca pk reporting, compartmental pk reporting, druginducedliverinjury, cloudbased web application kiwi, nonalcholic fatty liver disease, in vitro dissolution method design, in vitro permeability, free chemical sketching software, pbtk modeling

  • Technologies: Sendgrid, Outlook, MailChimp SPF, Zendesk, Microsoft Azure Hosting, Pantheon, Marketo, Adobe Media Optimizer, Cedexis Radar, Google Font API, Varnish, DoubleClick, Google Dynamic Remarketing, Google Analytics, Hotjar, Vimeo, WordPress.org, YouTube, Nginx, Linkedin Marketing Solutions, Mobile Friendly, DoubleClick Conversion, Google Tag Manager, reCAPTCHA, Gravity Forms, Remote

  • Year: 1996

  • Address: 42505 10th St W, Lancaster, California, United States, 93534-7011

  • Website URL: http://www.simulations-plus.com

  • LinkedIn URL:

  • Facebook URL:

  • Twitter URL:

  • Views: 29

Classiera WordPress theme

Description

SCIENCE + SOFTWARE = SUCCESS.


Company Overview
Simulations Plus, Inc. (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical trials/post-approval.

Comments

Leave a Comment

Your email address will not be published. Required fields are marked. *

Success! Thanks for your comment. We appreciate your response.
You might have left one of the fields blank, or be posting too quickly